ABALLI JOHN - Insider Non-Derivative Transactions at EXAGEN INC. (XGN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 16, 2025, ABALLI JOHN's relationship to EXAGEN INC. (XGN) is Director,Officer (President and CEO), and currently has 714,427 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XGN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

ABALLI JOHN - Insider Non-Derivative Transactions of XGN Common Stock

ABALLI JOHN - Insider Non-Derivative Transactions at XGN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 17, 2025	Sell -- (Common Stock)	31787	11.82	714427
Mar 1, 2025	Acquisition -- (Common Stock)	8621	2.47	746214
Feb 22, 2025	Acquisition -- (Common Stock)	112500	0	737593
Nov 15, 2024	P -- (Common Stock)	24305	2.81	689799
May 17, 2024	P -- (Common Stock)	40401	1.92	40401
Mar 1, 2024	Acquisition -- (Common Stock)	9804	1.91	600788
Feb 21, 2024	Acquisition -- (Common Stock)	175000	0	590984
Oct 18, 2023	Sell -- (Common Stock)	33819	1.75	415984
Sep 1, 2023	Acquisition -- (Common Stock)	9803	2.14	449803